FDA Issues Final Order Removing Two Sunscreen Ingredients from Monograph
FDA announced today (here) that, after reviewing timely submitted comments to its September 27, 2021 notice of availability of the proposed order OTC000008 titled Amending Over-the-Counter (OTC) Monograph M020, that it is removing two ingredients, para-aminobenzoic Acid (PABA) and trolamine salicylate from the monograph. The notice states that “FDA has determined that there are no […]
